Preview

Nephrology (Saint-Petersburg)

Advanced search

Soluble transferrin receptor and ferritin index in evaluation of iron metabolism in hemodialysis patients

Abstract

THE AIM: to study features of ferrokinetic in hemodialysis patients according to the level of soluble receptors of transferrin and ferritin index. PATIENTS AND METHODS. Research included 100 patients with chronic kidney disease 5D stage receiving hemodialysis, among them 51 women and 49 men, mean age was 53,4±15,8 years. All patients were performed complex clinical and laboratory tests. RESULTS. The increasing concentration of soluble transferrin receptors was observed in 44% of patients that can be caused by iron deficiency and increased erythropoiesis in response to therapy with erythropoietin. The level of hemoglobin is not varied depending on the concentration of soluble transferrin receptors. The estimation of genesis of anemia based on the ferritin index allowed to identify a higher frequency of anemia of chronic disease (92,5%) than using the traditional approach based on the level of ferritin and transferrin saturation (functional iron deficiency in 9% of patients). The combination of anemia in chronic disease with iron deficiency associated with low iron concentration and a high level of hepcidin. The negative role of hypoalbuminemia on the iron level, transferrin saturation and soluble receptor of transferrin was demonstrated (p<0.05). CONCLUSION. In dialysis patients for a comprehensive evaluation of iron metabolism, it is advisable to perform a study of soluble transferrin receptors and the calculation of ferritin index, which allow to assess the anemic syndrome formation pathogenetic mechanisms.

About the Authors

E. S. Lapina
Rostov State Medical University; Rostov regional clinical hospital
Russian Federation


M. M. Batiushin
Rostov State Medical University
Russian Federation


References

1. Смирнов АВ, Шилов ЕМ, Добронравов ВАидр. Национальные рекомендации. хроническая болезнь почек: основные принципы скрининга, диагностики, профилактики и подходы к лечению. Нефрология 2012; 16(1): 89-115

2. Смирнов АВ, Румянцев АШ, Добронравов ВА, Каюков ИГ. XXI век - время интегративной нефрологии Нефрология 2015; 19 (2): 22-26

3. Coresh J, Astor BC, Greene T et al. Prevalence of chronic kidney disease and decrease kidney function in adult. Am J Kidney Dis 2003; 41 (91): 1-12

4. Mc Clellan W, Aronoff SL, Bolton WK et al. The prevalence of anemia in patients with chronic kidney disease. Curr Med Ress Opion. 2004; 20: 1501-1510

5. Милованов ЮС, Милованова ЛЮ, Козловская ЛВ. Нефрогенная анемия: патогенез, прогностическое значение, принципы лечения. Клин нефрология 2010; 6: 7-18

6. Лапина ЕС, Батюшин ММ, Гуржиева КСидр. Метаболизм железа и гепсидина у пациентов с хронической болезнью почек С5Д стадии. Нефрология 2015; 5 (19): 81-85

7. Feelders RA, Kuiper-Kramer EPA, Henk G van Eijk. Structure, Function and Clinical Significance of Transferrin Receptors. Clinical Chemistry and Laboratory Medicine 2005; 37 (1): 1-10

8. Speeckaert MM, Speeckaert R, Delanghe JR. Biological and clinical spects of soluble transferrin receptor. Crit Rev Clin Lab Sci 2010 Dec; 47(5-6): 213-28. doi: 10.3109/10408363.2010.550461

9. Tarng DC, Huang TP. Determinants of circulating soluble transferrin receptor level in chronic haemodialysis patients. Nephrol Dial Transplant 2002 Jun; 17(6): 1063-1069

10. Castel R, Tax MG, Droogendijk J et al. The transferrin/ log(ferritin) ratio: a new tool for the diagnosis of iron deficiency anemia. Clin Chem Lab Med 2012; 50(8): 1343-9. doi: 10.1515/ cclm-2011-0594

11. Chen YC, Hung SC, Tarng DC. Association Between Transferrin Receptor-Ferritin Index and Conventional Measures of Iron Responsiveness in Hemodialysis Patients. Am J Kid Dis 2006; 47 (6): 1036-1044

12. Клинические практические рекомендации KDIGO по анемии при хронической болезни почек 2012 URL: http://www. kdigo.org/clinical_practice_guidelines/pdf/Anemia%20GL%20 %20Full%20Russian%20Translation.pdf (дата обращения: 13.01.2016)

13. Kalantar-Zadeh K, Kopple JD, Block G et al. A malnutritioninflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients. Am J Kidney Dis 2001; 38 (6): 1251-1263

14. Rishi G, Wallace DF, Subramaniam VN. Hepcidin: regulation of the master iron regulator. Biosci Rep 2015; 35(3). pii: e00192. doi: 10.1042/BSR20150014

15. Lukaszyk E, Lukaszyk M, Koc-Zorawska E et al. Iron Status and Inflammation in Early Stages of Chronic Kidney Disease. Kidney Blood Press Res 2015; 40(4): 366-373. doi: 10.1159/000368512.

16. Garibotto G, Sofia A, Saffioti S et al. Amino acid and protein metabolism in the human kidney and in patients with chronic kidney disease. Clin Nutr 2010 Aug; 29(4): 424-33. doi: 10.1016/j. clnu.2010.02.005


Review

For citations:


Lapina E.S., Batiushin M.M. Soluble transferrin receptor and ferritin index in evaluation of iron metabolism in hemodialysis patients. Nephrology (Saint-Petersburg). 2016;20(5):50-54. (In Russ.)

Views: 1446


ISSN 1561-6274 (Print)
ISSN 2541-9439 (Online)